Envoy Medical, INC S-1 registration statements

Envoy Medical, Inc. has filed an S-1MEF registration statement to offer an additional $13,437,500 in common stock and various warrants.

Envoy Medical, Inc. has amended its engagement letter with H.C. Wainwright & Co., LLC, adjusting fees and extending the term for a registered equity offering aiming to raise at least $30 million.

Envoy Medical, Inc. announces a new public offering of up to $25 million in Class A Common Stock and Warrants to fund its pivotal clinical study, while facing Nasdaq compliance challenges.

Envoy Medical, a hearing health company, is conducting a new offering of common stock and warrants to fund operations, while simultaneously addressing Nasdaq compliance issues and ongoing clinical trials for its Acclaim CI.

Envoy Medical, a hearing health company, filed an S-1/A registration statement to allow selling stockholders to resell up to 15.1 million shares, while detailing ongoing clinical trials for its Acclaim CI, significant financial losses, and Nasdaq compliance challenges.

Envoy Medical, a hearing health company, filed an S-1 registration statement for the resale of over 15 million shares by selling stockholders, while advancing its Acclaim cochlear implant clinical trials and addressing Nasdaq listing compliance.

Envoy Medical has filed a registration statement for the resale of a significant number of securities, which could lead to a decline in its stock price.

Envoy Medical seeks to register the issuance and resale of Class A Common Stock and warrants, potentially raising $203.4 million for general corporate purposes.

Envoy Medical has filed an amendment to its S-1 registration statement related to the potential issuance of Class A common stock upon exercise of warrants and conversion of preferred stock, as well as the resale of existing securities.

Envoy Medical seeks to register the issuance and resale of Class A Common Stock and warrants, potentially raising $46.7 million.